Back to Journals » Drug Design, Development and Therapy » Volume 11

Review

Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

       
Total article views   HTML views PDF downloads Totals
16,123 Dovepress* 13,701+ 1,680 15,381
PubMed Central* 2,422 478 2,900
Totals 16,123 2,158 18,281
*Since 21 March 2017

View citations on PubMed and Google Scholar